Long-term nephrotoxicity in adult survivors of childhood cancer.

BACKGROUND AND OBJECTIVES Because little is known about long-term treatment-related nephrotoxicity, the aim was to determine risk factors for renal impairment long after childhood cancer treatment. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS Data from 763 adult childhood cancer survivors (414 men) were obtained during regular visits at the late-effects clinic between 2003 and 2009. Median follow-up time was 18.3 years (range=5.0-58.2). Glomerular function was assessed by estimated GFR (using the Modification of Diet in Renal Disease formula), urinary albumin creatinine ratio, and tubular function by urinary β2-microglobulin creatinine ratio. The association with treatment factors was analyzed with covariance analysis for estimated GFR and logistic regression for urinary albumin and urinary β2-microglobulin creatinine ratios. RESULTS Survivors treated with nephrectomy and abdominal irradiation had significantly lower estimated GFR than survivors not treated with nephrectomy/abdominal irradiation (estimated mean=90 ml/min per 1.73 m(2) versus 106, P<0.001). Estimated GFR was significantly lower in survivors after treatment with high-dose ifosfamide (88 versus 98, P=0.02) and high-dose cisplatin (83 versus 101, P=0.004) compared with survivors not treated with these regimen. Nephrectomy combined with abdominal radiotherapy (odds ratio=3.14, 95% confidence interval=1.02; 9.69) and high-dose cisplatin (odds ratio=5.19, 95% confidence interval=1.21; 22.21) was associated with albuminuria. High-dose ifosfamide (odds ratio=6.19, 95% confidence interval=2.45; 15.67) was associated with increased urinary β2-microglobulin creatinine ratio. Hypertension was present in 23.4% of survivors and 31.4% of renal tumor survivors. CONCLUSIONS Treatment with unilateral nephrectomy, abdominal radiotherapy, cisplatin, and ifosfamide was associated with lower estimated GFR. Persisting tubular damage was related to ifosfamide treatment.

[1]  C. Koning,et al.  Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[2]  D. Hawkins,et al.  Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft‐tissue Sarcoma committee experience and rationale for current COG studies , 2012, Pediatric blood & cancer.

[3]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[4]  S. Yusuf,et al.  Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. , 2011, Kidney international.

[5]  R. Skinner.  Nephrotoxicity—What Do We Know and What Don't We Know? , 2011, Journal of pediatric hematology/oncology.

[6]  G. Burckhardt,et al.  New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2. , 2011, Molecular pharmaceutics.

[7]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[8]  M. Eijkemans,et al.  Pregnancy outcome in female childhood cancer survivors. , 2010, Human reproduction.

[9]  R. Foley,et al.  Long-term consequences of kidney donation. , 2009, The New England journal of medicine.

[10]  W. Weimar,et al.  Long-term consequences of kidney donation. , 2009, The New England journal of medicine.

[11]  G. Armstrong,et al.  Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Visser,et al.  Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. , 2008, Human reproduction.

[13]  D. Green,et al.  Renal late effects in patients treated for cancer in childhood: A report from the Children's Oncology Group , 2008, Pediatric blood & cancer.

[14]  Tom Greene,et al.  Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate (Annals of Internal Medicine (2006) 145, (247-254)) , 2008 .

[15]  L. Kiemeney,et al.  Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. , 2007, Kidney international.

[16]  G. Reaman,et al.  Hypertension and prehypertension in long‐term survivors of childhood and adolescent cancer , 2007, Pediatric blood & cancer.

[17]  Tom Greene,et al.  Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. , 2007, Clinical chemistry.

[18]  A. Garg,et al.  Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. , 2006, Kidney international.

[19]  K. Steinbeck,et al.  Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. , 2006, The Journal of clinical endocrinology and metabolism.

[20]  Kevin C Oeffinger,et al.  Chronic health conditions in adult survivors of childhood cancer. , 2006, The New England journal of medicine.

[21]  E. Christensen,et al.  Renal albumin absorption in physiology and pathology. , 2006, Kidney international.

[22]  D. de Zeeuw,et al.  The kidney, a cardiovascular risk marker, and a new target for therapy. , 2005, Kidney international. Supplement.

[23]  A. Murray,et al.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.

[24]  Hans L. Hillege,et al.  Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria , 2004, Circulation.

[25]  A. Craft,et al.  High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma , 2004, Cancer.

[26]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[27]  R. Skinner,et al.  Chronic ifosfamide nephrotoxicity in children. , 2003, Medical and pediatric oncology.

[28]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[29]  F. Zintl,et al.  Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function. , 2003, Medical and pediatric oncology.

[30]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[31]  J. Coresh,et al.  Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. , 2003, Kidney international.

[32]  B. Psaty,et al.  Cardiovascular disease risk status in elderly persons with renal insufficiency. , 2002, Kidney international.

[33]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  W. Hiddemann,et al.  Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients , 2001, European Journal of Clinical Pharmacology.

[35]  H. Groen,et al.  Clinical Pharmacokinetics and Pharmacodynamics of Ifosfamide and its Metabolites , 2001, Clinical Pharmacokinetics.

[36]  C. Bokemeyer,et al.  Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide. , 2000, Anticancer research.

[37]  M. Stevens,et al.  Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study , 2000, British Journal of Cancer.

[38]  C. Combe,et al.  Secretion of chemokines and cytokines by human tubular epithelial cells in response to proteins. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[40]  J. Ehrich,et al.  Renal involvement in children with malignancies , 1999, Pediatric Nephrology.

[41]  S. Izraeli,et al.  A prospective evaluation of ifosfamide‐related nephrotoxicity in children and young adults , 1995, Cancer.

[42]  R. Chesney,et al.  Renal toxicity of cancer chemotherapeutic agents in children: ifosfamide and cisplatin. , 1995, Current opinion in pediatrics.

[43]  M. Wharam,et al.  Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor. , 1994, The American journal of pediatric hematology/oncology.

[44]  A. Provoost,et al.  Renal function up to 50 years after unilateral nephrectomy in childhood. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  S. Klahr,et al.  Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. , 1987, Archives of internal medicine.

[46]  T. Barratt,et al.  Renal toxicity of cisplatin in children. , 1985, The Journal of pediatrics.

[47]  B. Brenner,et al.  Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. , 1982, The New England journal of medicine.

[48]  A. B. Maunsbach.  Albumin Absorption by Renal Proximal Tubule Cells , 1966, Nature.

[49]  Benjamin J. Epstein,et al.  Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure , 2007 .

[50]  P. Metharom,et al.  High molecular weight plasma proteins induce apoptosis and Fas/FasL expression in human proximal tubular cells. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[51]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[52]  D. Townsend,et al.  Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells. , 2003, Journal of the American Society of Nephrology : JASN.